SlideShare a Scribd company logo
INDUSTRY SURVEY RESULTS
WHAT ARE INDUSTRY PROFESSIONALS SAYING ABOUT THE FUTURE OF PRE-FILLED SYRINGES?
WHAT DO YOU BELIEVE TO BE THE BIGGEST
PROBLEMS CURRENTLY FACING THE PFS
INDUSTRY
Materials questions

Difficulty in prevention of
L&E into drug products
Threshold on
biological products
- are becoming too
viscous for current
technologies

Usability from
patient focus
32.9%

12.95%

Lack of uptake from major
industry eg. the NHS

WHAT DO YOU FIND TO BE THE MOST
IMPORTANT IN REGULATORY FACTORS

Updates on task
force initiates
5.18%

12.15%
32.00%

We asked leading experts their thoughts on the challenges
that the industry faces today and the opportunities for this
rapidly expanding sector, ahead of the Pre-Filled Syringes
Conference 2014.

21.22%

21.68%
*Some other answers include
•  imited flexibility in PFS designs
L
(volumes etc) particularily in
relation to weight based dosing
• Short Shelf Life
• Cost vs volume
• Stability data

Other*

ABOUT THE SURVEY
Pre-filled syringes are emerging as a huge growth segment
in the pharma industry, analysts predict it to reach $3.9bn
by 2015. This growth has triggered a wave of innovation in
injectables technology. Pharma companies world-wide are
now launching and converting products in the pre filled
market.

Interpretation of
analytical results
16.04%

New FDA
guidelines in
combination
products
45.88%

•  igh cost of disposable auto
H
injectors due to poor
syringe standardization etc
•  oor adherence and storage
P
by the users

Pre-Filled Syringes
Future applications for safer drug delivery
Marriot Regents Park Hotel, London, UK

PLASTIC VS GLASS: WHERE
DO YOU THINK THE FUTURE
DEVELOPMENT LIES

76.24%

WHAT DO YOU BELIEVE TO BE THE BIGGEST
ADVANCEMENTS RECENTLY WITH THE PFS
INDUSTRY
11.69%

Other*

Why glass:
• More neutral vs content

• Is less of an issue with LE

• Better quality

• Product stability

Why plastic:
• Low weight

(lower transportation costs)
• High robustness

• Tighter dimensions

• No breakage during filling procedure

• Compatibility with devices (e.g.

needle-free valves, pumps)
• Less safety issues, more control

• No silicone required


Plastic

Glass
23.76%

Attaining
high patient
safety in selfadministration
Meeting
changing
therapeutic
demands

6.90%

27.59%
41.38%

13.79%

*Some other answers include
•  septic filling optimization
A
•  he increasing need to perform Human Factor Studies
T
•  ntroduction of thinner needles
I

Advancements
in needle free
administration

Advancements
in drug stability
issues and
prevention of
leachables and
extratables

27th - 28th

JAN
2014

Now in its 6th year, the 2014 conference from the SMi
Group will bring together experts from a range of industry
perspectives to discuss solutions and strategies within key
issues such as syringe formulations for biosimilars and other
biologics, extractables and leachables, primary packaging
developments and filling and finishing.
Based on the online Pre-Filled Syringes Survey, of more
than 55 senior executives involved in the PFS Sector from
companies based in Europe and the USA, conducted by the SMi
Group in August-October 2013. This information is accurate
to the best of the respondents knowledge at that time, and
may subsequently have changed. The SMi Group cannot take
responsibility for the accuracy of this information.

For more information please visit www.pre-filled-syringes.com

More Related Content

What's hot

Oncology Drug Development Solutions
Oncology Drug Development SolutionsOncology Drug Development Solutions
Oncology Drug Development Solutions
Covance
 
The Statisticians Role in Pharmaceutical Development
The Statisticians Role in Pharmaceutical DevelopmentThe Statisticians Role in Pharmaceutical Development
The Statisticians Role in Pharmaceutical Development
Ashwani Dhingra
 
Electronic Compliance Monitoring
Electronic Compliance MonitoringElectronic Compliance Monitoring
Electronic Compliance Monitoring
wardsmith66
 
Selecting materials for medical devices | Insight, issue 5
Selecting materials for medical devices | Insight, issue 5Selecting materials for medical devices | Insight, issue 5
Selecting materials for medical devices | Insight, issue 5Team Consulting Ltd
 
Tuesday 2 fred kjellson clin_trials skane ab
Tuesday 2 fred kjellson clin_trials skane abTuesday 2 fred kjellson clin_trials skane ab
Tuesday 2 fred kjellson clin_trials skane abMichiel Stoffels
 
201706 medtech mdr_clinical_evaluation_investigation_ep_slide_share
201706 medtech mdr_clinical_evaluation_investigation_ep_slide_share201706 medtech mdr_clinical_evaluation_investigation_ep_slide_share
201706 medtech mdr_clinical_evaluation_investigation_ep_slide_share
Voisin Consulting Life Sciences
 
Four Practical Approaches To Managing A More Effective Device Trial
Four Practical Approaches To Managing A More Effective Device TrialFour Practical Approaches To Managing A More Effective Device Trial
Four Practical Approaches To Managing A More Effective Device TrialDavid Levin
 
Operations: Top Reasons for Long Lead Times and What to Do About Them
Operations: Top Reasons for Long Lead Times and What to Do About ThemOperations: Top Reasons for Long Lead Times and What to Do About Them
Operations: Top Reasons for Long Lead Times and What to Do About Them
April Bright
 
Pharmaceutical Sciences
Pharmaceutical SciencesPharmaceutical Sciences
Pharmaceutical Sciences
Obaid Ali / Roohi B. Obaid
 
Innovative Hospital Partnership Model for High Quality Patient Clinical Trials
Innovative Hospital Partnership Model for High Quality Patient Clinical TrialsInnovative Hospital Partnership Model for High Quality Patient Clinical Trials
Innovative Hospital Partnership Model for High Quality Patient Clinical Trials
SGS
 
Assessment of natural compound influence on periodontal clinical
Assessment of natural compound influence on periodontal clinicalAssessment of natural compound influence on periodontal clinical
Assessment of natural compound influence on periodontal clinical
Feng-wei Yeh
 
201705 topra india_atmp_fb_slide_share
201705 topra india_atmp_fb_slide_share201705 topra india_atmp_fb_slide_share
201705 topra india_atmp_fb_slide_share
Voisin Consulting Life Sciences
 
Consumer survey sheetal
Consumer survey sheetalConsumer survey sheetal
Consumer survey sheetal
sheetalsoni37
 
SMi Group's 9th annual Pre-filled Syringes Europe 2017
SMi Group's 9th annual Pre-filled Syringes Europe 2017 SMi Group's 9th annual Pre-filled Syringes Europe 2017
SMi Group's 9th annual Pre-filled Syringes Europe 2017
Dale Butler
 

What's hot (16)

Oncology Drug Development Solutions
Oncology Drug Development SolutionsOncology Drug Development Solutions
Oncology Drug Development Solutions
 
The Statisticians Role in Pharmaceutical Development
The Statisticians Role in Pharmaceutical DevelopmentThe Statisticians Role in Pharmaceutical Development
The Statisticians Role in Pharmaceutical Development
 
Electronic Compliance Monitoring
Electronic Compliance MonitoringElectronic Compliance Monitoring
Electronic Compliance Monitoring
 
Selecting materials for medical devices | Insight, issue 5
Selecting materials for medical devices | Insight, issue 5Selecting materials for medical devices | Insight, issue 5
Selecting materials for medical devices | Insight, issue 5
 
Tuesday 2 fred kjellson clin_trials skane ab
Tuesday 2 fred kjellson clin_trials skane abTuesday 2 fred kjellson clin_trials skane ab
Tuesday 2 fred kjellson clin_trials skane ab
 
201706 medtech mdr_clinical_evaluation_investigation_ep_slide_share
201706 medtech mdr_clinical_evaluation_investigation_ep_slide_share201706 medtech mdr_clinical_evaluation_investigation_ep_slide_share
201706 medtech mdr_clinical_evaluation_investigation_ep_slide_share
 
Four Practical Approaches To Managing A More Effective Device Trial
Four Practical Approaches To Managing A More Effective Device TrialFour Practical Approaches To Managing A More Effective Device Trial
Four Practical Approaches To Managing A More Effective Device Trial
 
Bioplastics: The Extension Professional's Role in Linking Science to Practice
Bioplastics: The Extension Professional's Role in Linking Science to PracticeBioplastics: The Extension Professional's Role in Linking Science to Practice
Bioplastics: The Extension Professional's Role in Linking Science to Practice
 
Operations: Top Reasons for Long Lead Times and What to Do About Them
Operations: Top Reasons for Long Lead Times and What to Do About ThemOperations: Top Reasons for Long Lead Times and What to Do About Them
Operations: Top Reasons for Long Lead Times and What to Do About Them
 
Pharmaceutical Sciences
Pharmaceutical SciencesPharmaceutical Sciences
Pharmaceutical Sciences
 
Innovative Hospital Partnership Model for High Quality Patient Clinical Trials
Innovative Hospital Partnership Model for High Quality Patient Clinical TrialsInnovative Hospital Partnership Model for High Quality Patient Clinical Trials
Innovative Hospital Partnership Model for High Quality Patient Clinical Trials
 
Assessment of natural compound influence on periodontal clinical
Assessment of natural compound influence on periodontal clinicalAssessment of natural compound influence on periodontal clinical
Assessment of natural compound influence on periodontal clinical
 
201705 topra india_atmp_fb_slide_share
201705 topra india_atmp_fb_slide_share201705 topra india_atmp_fb_slide_share
201705 topra india_atmp_fb_slide_share
 
Consumer survey sheetal
Consumer survey sheetalConsumer survey sheetal
Consumer survey sheetal
 
SMi Group's 9th annual Pre-filled Syringes Europe 2017
SMi Group's 9th annual Pre-filled Syringes Europe 2017 SMi Group's 9th annual Pre-filled Syringes Europe 2017
SMi Group's 9th annual Pre-filled Syringes Europe 2017
 
LIN-220715-newnew
LIN-220715-newnewLIN-220715-newnew
LIN-220715-newnew
 

Viewers also liked

Clubfoot & Cleft lip programs of LMRF in Bangladesh
Clubfoot & Cleft lip programs of LMRF in BangladeshClubfoot & Cleft lip programs of LMRF in Bangladesh
Clubfoot & Cleft lip programs of LMRF in Bangladesh
LMRF
 
Class 7 bangladesh & global studies capter 3 class 2
Class 7 bangladesh & global studies capter 3 class 2 Class 7 bangladesh & global studies capter 3 class 2
Class 7 bangladesh & global studies capter 3 class 2
Cambriannews
 
Top 20 Pharmaceutical Companies at risk: Market Share loses in Emerging Markets
Top 20 Pharmaceutical Companies at risk: Market Share loses in Emerging Markets Top 20 Pharmaceutical Companies at risk: Market Share loses in Emerging Markets
Top 20 Pharmaceutical Companies at risk: Market Share loses in Emerging Markets
Jose Ignacio Diaz
 
Class 6 bangladesh & global studies সমাজের কথা ১- পাঠ -5
Class 6 bangladesh & global studies সমাজের কথা ১- পাঠ -5Class 6 bangladesh & global studies সমাজের কথা ১- পাঠ -5
Class 6 bangladesh & global studies সমাজের কথা ১- পাঠ -5
Cambriannews
 
Biocon Investor Presentation Jan 2013
Biocon Investor Presentation Jan 2013Biocon Investor Presentation Jan 2013
Biocon Investor Presentation Jan 2013
Biocon
 
ADCC 2014 2017 market report_201312
ADCC 2014 2017 market report_201312ADCC 2014 2017 market report_201312
ADCC 2014 2017 market report_201312
JasonSoung
 
Class 7 bangladesh & global studies capter 5 class 1
Class 7 bangladesh & global studies capter 5 class 1Class 7 bangladesh & global studies capter 5 class 1
Class 7 bangladesh & global studies capter 5 class 1
Cambriannews
 
Class eight bangladesh & global studies chapter 1(lesson-5)
Class eight bangladesh & global studies chapter  1(lesson-5)Class eight bangladesh & global studies chapter  1(lesson-5)
Class eight bangladesh & global studies chapter 1(lesson-5)
Cambriannews
 
Indian Biotechnology Market
Indian Biotechnology MarketIndian Biotechnology Market
Indian Biotechnology Market
guestb32f9ed
 
Leveraging Patient Support Programs in Biologic-Biosimilar Competitive Landscape
Leveraging Patient Support Programs in Biologic-Biosimilar Competitive LandscapeLeveraging Patient Support Programs in Biologic-Biosimilar Competitive Landscape
Leveraging Patient Support Programs in Biologic-Biosimilar Competitive Landscape
Alex Xiaoguang Zhu
 
Health economics models and interchangeability of drugs v1.0
Health economics models and interchangeability of drugs v1.0Health economics models and interchangeability of drugs v1.0
Health economics models and interchangeability of drugs v1.0Goran Medic
 
Pharma industry 1-4_9_29_50
Pharma industry 1-4_9_29_50Pharma industry 1-4_9_29_50
Pharma industry 1-4_9_29_50domsr
 
Using Counter-biosimilar Messaging to Protect Your Brand
Using Counter-biosimilar Messaging to Protect Your BrandUsing Counter-biosimilar Messaging to Protect Your Brand
Using Counter-biosimilar Messaging to Protect Your Brand
Alex Xiaoguang Zhu
 
Math Lesson 5
Math Lesson 5Math Lesson 5
Math Lesson 5
Cambriannews
 
Using Behavior-based Market Sizing to Inform Global Medical Device Innovation...
Using Behavior-based Market Sizing to Inform Global Medical Device Innovation...Using Behavior-based Market Sizing to Inform Global Medical Device Innovation...
Using Behavior-based Market Sizing to Inform Global Medical Device Innovation...
Alex Xiaoguang Zhu
 
2014 APAC Consumer Health SMR Summary by IMS Health
2014 APAC Consumer Health SMR Summary by IMS Health2014 APAC Consumer Health SMR Summary by IMS Health
2014 APAC Consumer Health SMR Summary by IMS Health
QuintilesIMS Asia Pacific
 
Bangladesh final ppt.
Bangladesh final ppt. Bangladesh final ppt.
Bangladesh final ppt. Sunita Gurung
 
Regional Analysis of Asia
Regional Analysis of AsiaRegional Analysis of Asia
Regional Analysis of Asia
Ayman Sadiq
 
All About Infographics in 99 Seconds
All About Infographics in 99 SecondsAll About Infographics in 99 Seconds
All About Infographics in 99 Seconds
Ayman Sadiq
 
Bangladesh final ppt
Bangladesh final pptBangladesh final ppt
Bangladesh final ppt
Josephite
 

Viewers also liked (20)

Clubfoot & Cleft lip programs of LMRF in Bangladesh
Clubfoot & Cleft lip programs of LMRF in BangladeshClubfoot & Cleft lip programs of LMRF in Bangladesh
Clubfoot & Cleft lip programs of LMRF in Bangladesh
 
Class 7 bangladesh & global studies capter 3 class 2
Class 7 bangladesh & global studies capter 3 class 2 Class 7 bangladesh & global studies capter 3 class 2
Class 7 bangladesh & global studies capter 3 class 2
 
Top 20 Pharmaceutical Companies at risk: Market Share loses in Emerging Markets
Top 20 Pharmaceutical Companies at risk: Market Share loses in Emerging Markets Top 20 Pharmaceutical Companies at risk: Market Share loses in Emerging Markets
Top 20 Pharmaceutical Companies at risk: Market Share loses in Emerging Markets
 
Class 6 bangladesh & global studies সমাজের কথা ১- পাঠ -5
Class 6 bangladesh & global studies সমাজের কথা ১- পাঠ -5Class 6 bangladesh & global studies সমাজের কথা ১- পাঠ -5
Class 6 bangladesh & global studies সমাজের কথা ১- পাঠ -5
 
Biocon Investor Presentation Jan 2013
Biocon Investor Presentation Jan 2013Biocon Investor Presentation Jan 2013
Biocon Investor Presentation Jan 2013
 
ADCC 2014 2017 market report_201312
ADCC 2014 2017 market report_201312ADCC 2014 2017 market report_201312
ADCC 2014 2017 market report_201312
 
Class 7 bangladesh & global studies capter 5 class 1
Class 7 bangladesh & global studies capter 5 class 1Class 7 bangladesh & global studies capter 5 class 1
Class 7 bangladesh & global studies capter 5 class 1
 
Class eight bangladesh & global studies chapter 1(lesson-5)
Class eight bangladesh & global studies chapter  1(lesson-5)Class eight bangladesh & global studies chapter  1(lesson-5)
Class eight bangladesh & global studies chapter 1(lesson-5)
 
Indian Biotechnology Market
Indian Biotechnology MarketIndian Biotechnology Market
Indian Biotechnology Market
 
Leveraging Patient Support Programs in Biologic-Biosimilar Competitive Landscape
Leveraging Patient Support Programs in Biologic-Biosimilar Competitive LandscapeLeveraging Patient Support Programs in Biologic-Biosimilar Competitive Landscape
Leveraging Patient Support Programs in Biologic-Biosimilar Competitive Landscape
 
Health economics models and interchangeability of drugs v1.0
Health economics models and interchangeability of drugs v1.0Health economics models and interchangeability of drugs v1.0
Health economics models and interchangeability of drugs v1.0
 
Pharma industry 1-4_9_29_50
Pharma industry 1-4_9_29_50Pharma industry 1-4_9_29_50
Pharma industry 1-4_9_29_50
 
Using Counter-biosimilar Messaging to Protect Your Brand
Using Counter-biosimilar Messaging to Protect Your BrandUsing Counter-biosimilar Messaging to Protect Your Brand
Using Counter-biosimilar Messaging to Protect Your Brand
 
Math Lesson 5
Math Lesson 5Math Lesson 5
Math Lesson 5
 
Using Behavior-based Market Sizing to Inform Global Medical Device Innovation...
Using Behavior-based Market Sizing to Inform Global Medical Device Innovation...Using Behavior-based Market Sizing to Inform Global Medical Device Innovation...
Using Behavior-based Market Sizing to Inform Global Medical Device Innovation...
 
2014 APAC Consumer Health SMR Summary by IMS Health
2014 APAC Consumer Health SMR Summary by IMS Health2014 APAC Consumer Health SMR Summary by IMS Health
2014 APAC Consumer Health SMR Summary by IMS Health
 
Bangladesh final ppt.
Bangladesh final ppt. Bangladesh final ppt.
Bangladesh final ppt.
 
Regional Analysis of Asia
Regional Analysis of AsiaRegional Analysis of Asia
Regional Analysis of Asia
 
All About Infographics in 99 Seconds
All About Infographics in 99 SecondsAll About Infographics in 99 Seconds
All About Infographics in 99 Seconds
 
Bangladesh final ppt
Bangladesh final pptBangladesh final ppt
Bangladesh final ppt
 

Similar to Infographic pfs industry survey results

SMi Group's 7th annual Pre Filled Syringes conference & exhibition 2015
SMi Group's 7th annual Pre Filled Syringes conference & exhibition 2015SMi Group's 7th annual Pre Filled Syringes conference & exhibition 2015
SMi Group's 7th annual Pre Filled Syringes conference & exhibition 2015
Dale Butler
 
Searchforgrowthsurvey abslideshare-140507125927-phpapp01
Searchforgrowthsurvey abslideshare-140507125927-phpapp01Searchforgrowthsurvey abslideshare-140507125927-phpapp01
Searchforgrowthsurvey abslideshare-140507125927-phpapp01Alessandro Frandi
 
Searchforgrowthsurvey abslideshare-140507125927-phpapp01
Searchforgrowthsurvey abslideshare-140507125927-phpapp01Searchforgrowthsurvey abslideshare-140507125927-phpapp01
Searchforgrowthsurvey abslideshare-140507125927-phpapp01Alessandro Frandi
 
Final supply chain in pharma
Final supply chain in pharmaFinal supply chain in pharma
Final supply chain in pharmaJai Verma
 
Medical Device-Polymers & Plastics
Medical Device-Polymers & PlasticsMedical Device-Polymers & Plastics
Medical Device-Polymers & Plastics
InnoPlast Solutions
 
Biosimilars global congress 2014 europe copy 3 (6)
Biosimilars global congress 2014 europe  copy 3 (6)Biosimilars global congress 2014 europe  copy 3 (6)
Biosimilars global congress 2014 europe copy 3 (6)
chetanpatel73
 
NIPTE Conference 2016 Keynote Ajaz Hussain 09272016 Final
NIPTE Conference 2016 Keynote Ajaz Hussain 09272016 FinalNIPTE Conference 2016 Keynote Ajaz Hussain 09272016 Final
NIPTE Conference 2016 Keynote Ajaz Hussain 09272016 Final
Ajaz Hussain
 
2015 Dashboard of Pharmaceutical & Biologics Regulatory Sciences
2015 Dashboard of Pharmaceutical & Biologics Regulatory Sciences2015 Dashboard of Pharmaceutical & Biologics Regulatory Sciences
2015 Dashboard of Pharmaceutical & Biologics Regulatory Sciences
Obaid Ali / Roohi B. Obaid
 
Pre-Filled Syringes West Coast 2017
Pre-Filled Syringes West Coast 2017Pre-Filled Syringes West Coast 2017
Pre-Filled Syringes West Coast 2017
Fateja Begum
 
Single Use & Disposable Technology in Biomanufacturing
Single Use & Disposable Technology in BiomanufacturingSingle Use & Disposable Technology in Biomanufacturing
Single Use & Disposable Technology in Biomanufacturing
Pharma IQ
 
SMi Group's 2nd annual Prefilled Syringes America
SMi Group's 2nd annual Prefilled Syringes AmericaSMi Group's 2nd annual Prefilled Syringes America
SMi Group's 2nd annual Prefilled Syringes America
Dale Butler
 
P 141 pre-filled syringes america revised
P 141 pre-filled syringes america revisedP 141 pre-filled syringes america revised
P 141 pre-filled syringes america revised
Alia Malick
 
Pre-Filled Syringes West Coast 2017
Pre-Filled Syringes West Coast 2017Pre-Filled Syringes West Coast 2017
Pre-Filled Syringes West Coast 2017
Teri Arri
 
SMi Group's 2nd annual Pre-filled Syringes West Coast 2017
SMi Group's 2nd annual Pre-filled Syringes West Coast 2017SMi Group's 2nd annual Pre-filled Syringes West Coast 2017
SMi Group's 2nd annual Pre-filled Syringes West Coast 2017
Dale Butler
 
Chemometrics Pharmacometrics Econometrics of QbD Swiss Pharma-6 2012
Chemometrics Pharmacometrics Econometrics of QbD Swiss Pharma-6 2012Chemometrics Pharmacometrics Econometrics of QbD Swiss Pharma-6 2012
Chemometrics Pharmacometrics Econometrics of QbD Swiss Pharma-6 2012
Ajaz Hussain
 
PQRS-CCK (ICH- Q1) March 2017
PQRS-CCK (ICH- Q1) March 2017PQRS-CCK (ICH- Q1) March 2017
PQRS-CCK (ICH- Q1) March 2017
Obaid Ali / Roohi B. Obaid
 
Commercial considerations in early drug development
Commercial considerations in early drug developmentCommercial considerations in early drug development
Commercial considerations in early drug development
Sunil Ramkali
 
SMi Group's Pre-filled Syringes East Coast 2019
SMi Group's Pre-filled Syringes East Coast 2019SMi Group's Pre-filled Syringes East Coast 2019
SMi Group's Pre-filled Syringes East Coast 2019
Dale Butler
 
Effects of Working with Chemical Products in Your Health Breakthrough by Slid...
Effects of Working with Chemical Products in Your Health Breakthrough by Slid...Effects of Working with Chemical Products in Your Health Breakthrough by Slid...
Effects of Working with Chemical Products in Your Health Breakthrough by Slid...
CarolineNeves49
 
SMi Group's Prefilled Syringes West Coast 2019 conference
SMi Group's Prefilled Syringes West Coast 2019 conferenceSMi Group's Prefilled Syringes West Coast 2019 conference
SMi Group's Prefilled Syringes West Coast 2019 conference
Dale Butler
 

Similar to Infographic pfs industry survey results (20)

SMi Group's 7th annual Pre Filled Syringes conference & exhibition 2015
SMi Group's 7th annual Pre Filled Syringes conference & exhibition 2015SMi Group's 7th annual Pre Filled Syringes conference & exhibition 2015
SMi Group's 7th annual Pre Filled Syringes conference & exhibition 2015
 
Searchforgrowthsurvey abslideshare-140507125927-phpapp01
Searchforgrowthsurvey abslideshare-140507125927-phpapp01Searchforgrowthsurvey abslideshare-140507125927-phpapp01
Searchforgrowthsurvey abslideshare-140507125927-phpapp01
 
Searchforgrowthsurvey abslideshare-140507125927-phpapp01
Searchforgrowthsurvey abslideshare-140507125927-phpapp01Searchforgrowthsurvey abslideshare-140507125927-phpapp01
Searchforgrowthsurvey abslideshare-140507125927-phpapp01
 
Final supply chain in pharma
Final supply chain in pharmaFinal supply chain in pharma
Final supply chain in pharma
 
Medical Device-Polymers & Plastics
Medical Device-Polymers & PlasticsMedical Device-Polymers & Plastics
Medical Device-Polymers & Plastics
 
Biosimilars global congress 2014 europe copy 3 (6)
Biosimilars global congress 2014 europe  copy 3 (6)Biosimilars global congress 2014 europe  copy 3 (6)
Biosimilars global congress 2014 europe copy 3 (6)
 
NIPTE Conference 2016 Keynote Ajaz Hussain 09272016 Final
NIPTE Conference 2016 Keynote Ajaz Hussain 09272016 FinalNIPTE Conference 2016 Keynote Ajaz Hussain 09272016 Final
NIPTE Conference 2016 Keynote Ajaz Hussain 09272016 Final
 
2015 Dashboard of Pharmaceutical & Biologics Regulatory Sciences
2015 Dashboard of Pharmaceutical & Biologics Regulatory Sciences2015 Dashboard of Pharmaceutical & Biologics Regulatory Sciences
2015 Dashboard of Pharmaceutical & Biologics Regulatory Sciences
 
Pre-Filled Syringes West Coast 2017
Pre-Filled Syringes West Coast 2017Pre-Filled Syringes West Coast 2017
Pre-Filled Syringes West Coast 2017
 
Single Use & Disposable Technology in Biomanufacturing
Single Use & Disposable Technology in BiomanufacturingSingle Use & Disposable Technology in Biomanufacturing
Single Use & Disposable Technology in Biomanufacturing
 
SMi Group's 2nd annual Prefilled Syringes America
SMi Group's 2nd annual Prefilled Syringes AmericaSMi Group's 2nd annual Prefilled Syringes America
SMi Group's 2nd annual Prefilled Syringes America
 
P 141 pre-filled syringes america revised
P 141 pre-filled syringes america revisedP 141 pre-filled syringes america revised
P 141 pre-filled syringes america revised
 
Pre-Filled Syringes West Coast 2017
Pre-Filled Syringes West Coast 2017Pre-Filled Syringes West Coast 2017
Pre-Filled Syringes West Coast 2017
 
SMi Group's 2nd annual Pre-filled Syringes West Coast 2017
SMi Group's 2nd annual Pre-filled Syringes West Coast 2017SMi Group's 2nd annual Pre-filled Syringes West Coast 2017
SMi Group's 2nd annual Pre-filled Syringes West Coast 2017
 
Chemometrics Pharmacometrics Econometrics of QbD Swiss Pharma-6 2012
Chemometrics Pharmacometrics Econometrics of QbD Swiss Pharma-6 2012Chemometrics Pharmacometrics Econometrics of QbD Swiss Pharma-6 2012
Chemometrics Pharmacometrics Econometrics of QbD Swiss Pharma-6 2012
 
PQRS-CCK (ICH- Q1) March 2017
PQRS-CCK (ICH- Q1) March 2017PQRS-CCK (ICH- Q1) March 2017
PQRS-CCK (ICH- Q1) March 2017
 
Commercial considerations in early drug development
Commercial considerations in early drug developmentCommercial considerations in early drug development
Commercial considerations in early drug development
 
SMi Group's Pre-filled Syringes East Coast 2019
SMi Group's Pre-filled Syringes East Coast 2019SMi Group's Pre-filled Syringes East Coast 2019
SMi Group's Pre-filled Syringes East Coast 2019
 
Effects of Working with Chemical Products in Your Health Breakthrough by Slid...
Effects of Working with Chemical Products in Your Health Breakthrough by Slid...Effects of Working with Chemical Products in Your Health Breakthrough by Slid...
Effects of Working with Chemical Products in Your Health Breakthrough by Slid...
 
SMi Group's Prefilled Syringes West Coast 2019 conference
SMi Group's Prefilled Syringes West Coast 2019 conferenceSMi Group's Prefilled Syringes West Coast 2019 conference
SMi Group's Prefilled Syringes West Coast 2019 conference
 

More from Yulia Rotar

Border Security - 2014, February, Sofia, Bulgaria
Border Security - 2014, February, Sofia, BulgariaBorder Security - 2014, February, Sofia, Bulgaria
Border Security - 2014, February, Sofia, Bulgaria
Yulia Rotar
 
European smart grid cyber and scada security
European smart grid cyber and scada securityEuropean smart grid cyber and scada security
European smart grid cyber and scada security
Yulia Rotar
 
Gas to liquids north america
Gas to liquids north americaGas to liquids north america
Gas to liquids north america
Yulia Rotar
 
Pre filled syringes americas
Pre filled syringes americasPre filled syringes americas
Pre filled syringes americas
Yulia Rotar
 
Biosimilars & biobetters usa
Biosimilars & biobetters usaBiosimilars & biobetters usa
Biosimilars & biobetters usaYulia Rotar
 

More from Yulia Rotar (6)

Border Security - 2014, February, Sofia, Bulgaria
Border Security - 2014, February, Sofia, BulgariaBorder Security - 2014, February, Sofia, Bulgaria
Border Security - 2014, February, Sofia, Bulgaria
 
European smart grid cyber and scada security
European smart grid cyber and scada securityEuropean smart grid cyber and scada security
European smart grid cyber and scada security
 
Gas to liquids north america
Gas to liquids north americaGas to liquids north america
Gas to liquids north america
 
Pre filled syringes americas
Pre filled syringes americasPre filled syringes americas
Pre filled syringes americas
 
Biosimilars & biobetters usa
Biosimilars & biobetters usaBiosimilars & biobetters usa
Biosimilars & biobetters usa
 
P 113 geriatric
P 113 geriatricP 113 geriatric
P 113 geriatric
 

Infographic pfs industry survey results

  • 1. INDUSTRY SURVEY RESULTS WHAT ARE INDUSTRY PROFESSIONALS SAYING ABOUT THE FUTURE OF PRE-FILLED SYRINGES? WHAT DO YOU BELIEVE TO BE THE BIGGEST PROBLEMS CURRENTLY FACING THE PFS INDUSTRY Materials questions Difficulty in prevention of L&E into drug products Threshold on biological products - are becoming too viscous for current technologies Usability from patient focus 32.9% 12.95% Lack of uptake from major industry eg. the NHS WHAT DO YOU FIND TO BE THE MOST IMPORTANT IN REGULATORY FACTORS Updates on task force initiates 5.18% 12.15% 32.00% We asked leading experts their thoughts on the challenges that the industry faces today and the opportunities for this rapidly expanding sector, ahead of the Pre-Filled Syringes Conference 2014. 21.22% 21.68% *Some other answers include • imited flexibility in PFS designs L (volumes etc) particularily in relation to weight based dosing • Short Shelf Life • Cost vs volume • Stability data Other* ABOUT THE SURVEY Pre-filled syringes are emerging as a huge growth segment in the pharma industry, analysts predict it to reach $3.9bn by 2015. This growth has triggered a wave of innovation in injectables technology. Pharma companies world-wide are now launching and converting products in the pre filled market. Interpretation of analytical results 16.04% New FDA guidelines in combination products 45.88% • igh cost of disposable auto H injectors due to poor syringe standardization etc • oor adherence and storage P by the users Pre-Filled Syringes Future applications for safer drug delivery Marriot Regents Park Hotel, London, UK PLASTIC VS GLASS: WHERE DO YOU THINK THE FUTURE DEVELOPMENT LIES 76.24% WHAT DO YOU BELIEVE TO BE THE BIGGEST ADVANCEMENTS RECENTLY WITH THE PFS INDUSTRY 11.69% Other* Why glass: • More neutral vs content • Is less of an issue with LE • Better quality • Product stability Why plastic: • Low weight (lower transportation costs) • High robustness • Tighter dimensions • No breakage during filling procedure • Compatibility with devices (e.g. needle-free valves, pumps) • Less safety issues, more control • No silicone required Plastic Glass 23.76% Attaining high patient safety in selfadministration Meeting changing therapeutic demands 6.90% 27.59% 41.38% 13.79% *Some other answers include • septic filling optimization A • he increasing need to perform Human Factor Studies T • ntroduction of thinner needles I Advancements in needle free administration Advancements in drug stability issues and prevention of leachables and extratables 27th - 28th JAN 2014 Now in its 6th year, the 2014 conference from the SMi Group will bring together experts from a range of industry perspectives to discuss solutions and strategies within key issues such as syringe formulations for biosimilars and other biologics, extractables and leachables, primary packaging developments and filling and finishing. Based on the online Pre-Filled Syringes Survey, of more than 55 senior executives involved in the PFS Sector from companies based in Europe and the USA, conducted by the SMi Group in August-October 2013. This information is accurate to the best of the respondents knowledge at that time, and may subsequently have changed. The SMi Group cannot take responsibility for the accuracy of this information. For more information please visit www.pre-filled-syringes.com